Resolving Clinically Indeterminate Findings During Anal Cancer Surveillance with TTMV-HPV DNA

TTMV-HPV DNA testing reliably clarifies clinically indeterminate findings during ASCC surveillance, demonstrating high accuracy (92%) and earlier detection of recurrence. These data support integration into post-treatment management to reduce diagnostic uncertainty and guide timely care.